Free Trial
OTCMKTS:QTXB

QuantRx Biomedical (QTXB) Stock Price, News & Analysis

About QuantRx Biomedical Stock (OTCMKTS:QTXB)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
26,433 shs
Market Capitalization
$39,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Receive QTXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuantRx Biomedical and its competitors with MarketBeat's FREE daily newsletter.

QTXB Stock News Headlines

QuantRx Biomedical Corporation (QTXB)
Best Biomedical Engineering Programs
Trump Knows Exactly What He's Doing
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
Quantrx Biomedical Corp QTXB
Global Biomedical Tester Market Research Report 2022-2032
QTXB.PK - | Stock Price & Latest News | Reuters
See More Headlines

QTXB Stock Analysis - Frequently Asked Questions

Shares of QTXB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that QuantRx Biomedical investors own include Augusta Gold (AUGG), Auxly Cannabis Group (CBWTF), Christopher & Banks (CBK), Babcock & Wilcox Enterprises (BW), Ascent Solar Technologies (ASTI), Arch Therapeutics (ARTH) and Amerigo Resources (ARREF).

Company Calendar

Today
5/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:QTXB
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$39,000.00
Optionable
Not Optionable
Beta
-4.30
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:QTXB) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners